Tesla and Facebook advance in pre-market as the Nasdaq nears a new record

Congress loves a Big Pharma villain. But will that lead to any real policy changes on drug prices?

AbbVie has never been shy about guarding its patents and hiking drug prices. Congress tore into the company this week. But will it lead to any real policy change? Read More

The women’s employment crisis is far from over—and January’s jobs report proves it

In January 2022, 27 more times men than women joined the labor force. Read More

‘Crypto kryptonite’: A digital euro would be dual threat to banks and fintechs, a critical new report warns

The European Central Bank could decide as early as April whether to push ahead with its planning for a digital euro, a move closely watched by the banking and tech sectors. Read More